Metanolic extract of Malpighia emarginata bagasse: phenolic compounds and inhibitory potential on digestive enzymes  by Marques, Tamara R. et al.
OM
c
T
V
L
a
A
R
A
A
K
M


L
T
I
I
o
p
h
i
s
p
m
b
m
m
M
e
(
a
0Revista Brasileira de Farmacognosia 26 (2016) 191–196
ww w.elsev ier .com/ locate /b jp
riginal  Article
etanolic  extract  of  Malpighia  emarginata  bagasse:  phenolic
ompounds  and  inhibitory  potential  on  digestive  enzymes
amara  R.  Marques ∗, Aline  A.  Caetano,  Anderson  A.  Simão,  Flávia  Cíntia  de  O.  Castro,
inicius  de  Oliveira  Ramos,  Angelita  D.  Corrêa
aboratório de Bioquímica, Departamento de Química, Universidade Federal de Lavras, Lavras, MG, Brazil
 r  t i  c  l  e  i  n  f  o
rticle history:
eceived 16 May  2015
ccepted 18 August 2015
vailable online 29 November 2015
eywords:
alpighia emarginata
-Amylase
-Glucosidase
a  b  s  t  r  a  c  t
Adding  value  to fruit residues  is of great  interest,  since  they  can  be  presented  as  a viable  solution
in  search  of new  drugs  for  the treatment  of obesity  and  related  diseases,  due  to  bioactive  substances,
especially  phenolic  compounds.  Thus,  the  objective  of this  study  was  to prepare  the  methanol  extract  of
acerola bagasse  ﬂour,  in order to evaluate  its  potential  as a  source  of inhibitors  of the  enzymes  -amylase,
-glucosidase,  lipase  and  trypsin,  and  determine  the  content  of  phenolic  compounds  by  high  performance
liquid  chromatography.  Enzymatic  inhibition  assays  were  conducted  in the  presence  or absence  of sim-
ulated  gastric  ﬂuid.  In the  methanol  extract  of  acerola  bagasse  ﬂour,  the following  phenolic  compounds
were  identiﬁed:  gallic  acid,  syringic  and  p-coumaric  acid,  catechin,  epigallocatechin  gallate,  epicatechin
and  quercetin;  epicatechin  was  the  major  compound.  In the absence  of  gastric  ﬂuid, simulated  enzymesipase
rypsin
nhibitor
had  a variable  inhibition  of  the  acerola  bagasse  ﬂour  extract,  except  for  lipase, which  was  not  inhibited.
In  the  presence  of  simulated  gastric  ﬂuid,  there  was  an  inhibition  of  170.08  IEU  (Inhibited  Enzyme  Unit
in  mol  min−1 g−1)  for  -amylase  and  69.29  IEU for -glucosidase,  indicating  that  this  extract  shows
potential as an adjuvant  in  the  treatment  of  obesity  and  other  dyslipidemia.
© 2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Obesity is a disease resulting from the excessive accumulation
f body fat, and brings multiple outcomes for health, such as the
revalence and progression of cardiovascular diseases (especially
eart diseases and stroke), which were the major causes of death
n 2012; Some types of cancer (endometrium, breast and colon);
keletal muscle disturbs (specially osteoarthritis – a highly inca-
acitating degenerative disease); hypertension and type 2 diabetes
ellitus (Wanderley and Ferreira, 2010; WHO, 2015).
Between 1980 and 2014, the world’s obesity prevalency dou-
led. Data from the World Health Organization report that, in 2014,
ore than 1.9 billion adults were overweight and, among them,
ore than 600 million were obese (WHO, 2015).
One way to ﬁght this epidemic disease is drug treatment.
edicine to ﬁght weight gain, which has the objective to restrict
nergy absorption and cause weight loss, is widely available
Boniglia et al., 2008). However, these drugs cause side effects
nd are prohibited by Anvisa since 2011 (Abeso, 2014). Another
∗ Corresponding author.
E-mail: angelita@dqi.uﬂa.br (T.R. Marques).
http://dx.doi.org/10.1016/j.bjp.2015.08.015
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraalternative broadly employed is the use of plant extracts. Over the
last years, there was  a substantial increase in its use, by the fact
that the population believes its intake is harmless, with a low cost,
and may  inhibit digestive enzymes, leading to beneﬁcial changes in
metabolism (Simão et al., 2012). However not all natural products
are beneﬁcial and further studies are necessary to evaluate their
effects on the organism.
Enzymes like -amylase and -glycosidase, responsible for
processing dietary carbohydrates, act on starch breakdown, result-
ing in monosaccharide absorption by enterocytes. Therefore, their
inhibition offers a promising strategy for the prevention of obesity,
as well as type 2 diabetes associated to hyperglycemia, by inhibi-
ting starch breakdown and glucose absorption in the small intestine
(Kwon et al., 2008; Balasubramaniam et al., 2013).
Lipase, involved in fat metabolism, is also an important target
for inhibitors, since its inhibition limits triacylglycerol absorption,
leading to a decrease in caloric yield and weight loss. On the other
hand, trypsin inhibition, involved in protein digestion, has a maleﬁc
effect, once it impairs the complete amino acid absorption in food,
essential for the organism.
Research has been carried out for evaluating the effects of
natural products on the treatment of obesity and associated comor-
bidities, reinforcing the need for the search of new sources of
 Ltda. All rights reserved.
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mylase, glycosidase and lipase inhibitors (Souza et al., 2011;
ereira et al., 2011a; Simão et al., 2012). Therefore, digestive
nhibitors who assist in reducing fat and carbohydrate absorption
n the small intestine may  be useful helpers in the treatment of
besity.
Natural products have been gaining space and importance in
he pharmaceutical industry, since they have bioactive substances
apable of inspiring new phytomedicines and phytotherapic prod-
cts. Phenolic compounds are among those substances. These
ompounds present chemical structures with hydroxyls and aro-
atic rings, which can be simple structures or polymers, originated
rom plant secondary metabolism and largely found in fruits
Angelo and Jorge, 2007). Many studies report the beneﬁts of phe-
olic compounds as an adjunct in the treatment of obesity (Klaus
t al., 2005; Hen et al., 2006; Alterio et al., 2007; Santiago-Mora
t al., 2011; Vogel et al., 2015; Zhang et al., 2015).
Alterio et al. (2007) and Klaus et al. (2005) report that phe-
olic compounds act in the prevention of obesity due to their
hermogenic effects, ability to oxidize body fat and by decreasing
ntestinal absorption of fats and carbohydrates caused by the inhi-
ition of digestive enzymes, resulting in weight loss. Phenolic
ompounds, such as tannins, have the ability of combining with
igestive enzymes, proteins and other polymers (such as carbo-
ydrates), forming stable complexes, impairing absorption and,
herefore, making them possible inhibitors of some of these diges-
ive enzymes (Won  et al., 2007; Gholamhoseinian et al., 2010).
In this context, the use of agro industrial residues of fruits
s promising for the extraction of active principles that may  be
mployed as an alternative to the treatment of obesity and corre-
ated diseases. By discarding these residues, secondary metabolites
f great aggregated value with possible applications in pharma-
eutical and food industries, are also eliminated. For example,
he acerola bagasse originated in juice processing is, according to
arques et al. (2013), rich in phenolic compounds, with record
ontents of 10.82 g 100 g−1 dry matter; however, these phenolic
ompounds were not yet identiﬁed.
Given the above, the objective of the present study was  to
repare the methanol extract of acerola bagasse ﬂour (ABF), eval-
ate its potential as a source of -amylase, -glycosidase, lipase
nd trypsin inhibitors, and determine the phenolic compounds by
igh performance liquid chromatography (HPLC), aiming to use it
s an auxiliary in the treatment of obesity and correlated diseases,
ggregating value to this residue.
aterial and methods
reparation of acerola bagasse ﬂour
Acerola Malpighia emarginata DC., Malpighiaceae (BRS 238 Fru-
acor) bagasse was obtained from plants grown in the municipality
f Perdões, MG,  Brazil (21◦05′27′′ S; 45◦05′27′′ W,  848 m altitude);
he local climate according to the Köppen system is classiﬁed as
wa: mild and rainy summers with moderate temperatures, annual
verage temperature below 21 ◦C, average annual precipitation of
529.7 mm,  and relative humidity of 76% (Emater, 2002). Acerola
ruits were used for pulp extraction, and the residual bagasse was
rovided in three batches by a fruit pulp plant ﬁrm located in
erdões, MG,  Brazil.
Acerola bagasse (4 kg) was frozen at −18 ◦C and lyophilized in
lass containers protected from light for 7 days to obtain 450 g
ry bagasse. After lyophilization, acerola bagasse was homogenized
sing mortar and pestle, was passed in sieves and most ﬂour parti-
les were retained on sieves sized 40 mesh (0.425 mm)  to 80 mesh
0.180 mm),  thus, classiﬁed as ﬁne and then placed in a hermetically
ealed ﬂask, protected from light in a refrigerator at 4 ◦C.armacognosia 26 (2016) 191–196
Obtention of the extract
To obtain the methanol extract of acerola bagasse ﬂour (ABF), 1 g
of acerola bagasse lyophilized powder was transferred to a 250 ml
erlenmeyer and then added 50 ml of 50% methanol solution in three
repetitions. Afterwards, it covered with a ground glass joint and
put on a hot plate at 80 ◦C. After boiling for 15 min, the extract was
ﬁltered in ﬁlter paper and collected to a 250 ml  becker. The residue
was once again put on an erlenmeyer and this process repeated for
two more times. After the third ﬁltration, the becker was  taken to
the hot plate to evaporate the methanol until the volume reaches
16 ml  (AOAC, 2012), and then submitted to enzymatic inhibition
analysis.
For the chromatography process, the becker was taken to the hot
plate to evaporate the methanol, posteriorly frozen and lyophilized
(Free Zone® 2.5 liter Freeze Dry Sustems). Lyophilyzed extract (1 g)
was solubilized in 16 ml  ultrapure water obtained from a Milli-Q
system (EMD Millipore, Billerica, MA,  USA).
Identiﬁcation and quantiﬁcation of phenolic compounds
HPLC was performed using a Shimadzu UHPLC chromatograph
(Shimadzu Corporation, Kyoto, Japan) equipped with two  LC-20AT
high-pressure pumps, an SPD-M20A UV–vis detector, a CTO-20AC
oven, a CBM-20A interface, and an automatic injector with an SIL-
20A auto sampler. Separations were performed using a Shim-pack
VP-ODS-C18 (250 mm × 4.6 mm)  column, connected to a Shim-
pack Column Holder (10 mm × 4.6 mm)  pre-column (Shimadzu,
Japan).
The mobile phase consisted of the following solutions: 2% acetic
acid in water (A) and methanol:water:acetic acid (70:28:2, v/v/v)
(B). Analyses were performed for a total time of 65 min at 40 ◦C, ﬂux
of 1 ml  min−1, wavelength of 280 nm,  and injection volume of 20 l
in a gradient-type system (100% solvent A from 0.01 to 5 min; 70%
solvent A from 5 to 25 min; 60% solvent A from 25 to 43 min; 55%
solvent A from 43 to 50 min; and 0% solvent A for 10 min) until the
end of the run. Solvent A was increased to 100%, seeking to main-
tain a balanced column. Acetic acid and methanol (HPLC grade;
Sigma–Aldrich, USA) were used in the preparation of the mobile
phase.
Addition of standards to the extracts was  also used as an
identiﬁcation parameter. The phenolic standards used were gal-
lic acid, catechin, epigallocatechin gallate, epicatechin, syringic
acid, p-coumaric acid, ferulic acid, salicylic acid, resveratrol and
quercetin all obtained from Sigma–Aldrich (St. Louis, MO,  USA). The
stock standard solutions were prepared in methanol (HPLC grade;
Sigma–Aldrich, USA).
The ABF extract and the standards were ﬁltered through a 0.45-
m nylon membrane (EMD Millipore, USA) and directly injected
into the chromatographic system, in three replicates. The pheno-
lic compounds in the extract were identiﬁed by comparison with
retention times of standards. Quantiﬁcation was performed by
the construction of analytical curves obtained by linear regression
using Origin 6.1 computer software (OriginLab, Northampton, MA,
USA) and considering the coefﬁcient of determination (R2) equal to
0.99.
Enzyme obtention
Were used in the assays the enzymes: porcine pancreatic
lypase (EC 3.1.1.3) type II, Sigma; porcine pancreatic -amylase
(EC 3.2.1.1) type VI B, Sigma and porcine pancreatic trypsin (EC
3.4.21.4), Merck. The -glycosidase (EC 3.2.1.20) was  obtained from
fresh porcine duodenum according to Souza et al. (2011). The super-
natant was collected and used as an enzymatic extract.
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pig. 1. Chromatogram of acerola bagasse ﬂour extract, with peak identiﬁcation: (1) G
time  = 11.987 min); (4) epicatechin (time = 13.139 min); (5) syringic acid (time = 14
ctivity of ˛-amylase, ˛-glucosidase, lipase and trypsin
The -amylase activity was determined using the methodology
roposed by Noelting and Bernfeld (1948). Thus, the extract and -
mylase enzyme were pre-incubated for 20 min, in a water bath at
7 ◦C. The substrate was the 1% starch prepared in Tris 0.05 mol  l−1,
H 7.0 buffer with 38 mmol  l−1 NaCl and 0.1 mmol  l−1 CaCl2. After
ddition of 100 l of the substrate, the mixture was incubated for
our periods of time. The reaction was interrupted adding 200 l of
.5 dinitrosalicylic acid and the product read in spectrophotometer
t 540 nm.
The -glucosidase activity was determined according to Kwon
t al. (2008), using 5 mmol  l−1 p-nitrophenyl--d-glucopyranoside
n a 0.1 mol  l−1 pH 7.0 citrate–phosphate buffer as substrate. In the
ssay, extract and -glucosidase enzyme were incubated in a water
ath, at 37 ◦C, for four periods of time, after addition of the sub-
trate. The reaction was interrupted adding 1.000 l of 0.05 mol  l−1
aOH and the product was read in a spectrophotometer at 410 nm.
The lipase activity was determined according to Souza et al.
2011), using 8 mmol  l−1 p-nitrophenylpalmitate in Tris–HCl
.05 mmol  l−1, pH 8.0 buffer containing 0.5% Triton-X100 as sub-
trate. In the assay, extract and lipase enzyme was incubated in a
ater bath, at 37 ◦C, for four periods of time, after addition of the
ubstrate. The reaction was stopped, transferring the tubes to an
ce bath and adding Tris–HCl 0.05 mmol  l−1 pH 8.0 buffer. The p-
itrophenol, of yellow coloration, a product of the lipase action
n p-nitrophenylpalmitate, was read in a spectrophotometer at
10 nm.
The trypsin activity was determined according to the method-
logy proposed by Erlanger et al. (1961). Thus, extract and trypsin
nzyme were incubated in a water bath, at 37 ◦C, for four periods
f time, after addition of p-benzoyl-dl-arginine-p-nitroanilide sub-
trate (BApNA), prepared in Tris 0.05 mol  l−1, pH 8.2. The reaction
as interrupted adding 200 l of 30% acetic acid and the product
ead in a spectrophotometer at 410 nm.
For each assay of enzymatic activity, the volume of extract was
ifferent and its dilution ranged so that the enzyme inhibition
anged from 50 to 80%, according to the methodology.
The inhibition of the enzymes were obtained from the deter-
ination of the slopes of the straight lines (absorbance × time) of
he control enzyme (without extract) and enzymes + inhibitor (with
xtract) activity assays. The slope of the straight line is due to the
peed of product formation per minute of reaction and the presence
f the inhibitor causes a decrease in that inclination. From that incli-
ation, the absorbance values were converted into micromoles of
roduct through a standard glucose curve for the amylase and ofcid (time = 6.541 min); (2) catechin (time = 10.419 min); (3) epigallocatechin gallate
in); (6) p-coumaric acid (time = 19.892 min) and (7) quercetin (time = 51.185 min).
p-nitrophenol for glycosidase and lipase, while, for the trypsin, the
of BApNA molar extinction coefﬁcient determined by Erlanger et al.
(1961) was used.
Preparation of simulated gastric ﬂuid
With the objective of simulating the digestion process in the
stomach in vitro, enzymatic activity assays in the presence of a sim-
ulated gastric ﬂuid were also carried out. For such, the extract was
incubated with the simulated gastric ﬂuid prepared according to
The United States and Pharmacopeia, (2005), for 1 h in a water bath
at 37 ◦C. Subsequently, was neutralized with sodium bicarbonate
salt to pH 7.2 and only then realized the activity assays.
Results and discussion
Each 100 g ABF yielded 48 g of lyophilized extract (48% yield).
The following phenolic compounds were identiﬁed in the ABF
extract, in mg  l−1: gallic acid (3.32 ± 0.23), catechin (11.33 ± 0.33),
epigallocatechin gallate (9.13 ± 0.89), epicatechin (91.86 ± 1.49),
syringic acid (37.16 ± 0.12), p-coumaric acid (2.41 ± 0.13) and
quercetin (0.29 ± 0.02) (Fig. 1); gallic acid is a hydrolyzable tannin
monomer, and epigallocatechin gallate, catechin and epicatechin
are condensed tannin monomers. It was possible to observe that
epicatechin had the highest content, followed by syringic acid. The
compounds epicatechin, ferulic acid, salicylic acid and resveratrol
were not identiﬁed in the ABF extract.
Lin and Lin-Shiau (2006), Alterio et al. (2007), Cho et al. (2010)
and Rains et al. (2011) reported that phenolic compounds such as
caffeic and chlorogenic acid, catechin, epigallocatechin gallate and
quercetin have thermogenic effect, ability to oxidize fats, control
appetite, regulate levels of hormones related to obesity and inhibit
digestive enzymes involved in the absorption of carbohydrates and
lipids. Thus, this study shows that the acerola bagasse extract has
bioactive substances and can be exploited by the pharmaceutical
industry in search of drugs to control obesity and related diseases.
The results for enzymatic inhibition of ABF before the expo-
sure to gastric ﬂuids are shown in Table 1. The ABF methanol
extract inhibited the activity of -amylase, presenting an inhi-
bition potential of 238.96 mol  min−1 g−1 dry matter – DM.
This potential exceeds the one found by Pereira et al. (2011b),
who analyzed the white bean crude extract and detected an
inhibition of 54.1 mol  min−1 g−1. Simão et al. (2012), study-
ing aqueous extracts of medicinal plants, observed an inhibition
of 2907.13 mol  min−1 g−1 DM for Tournefortia paniculata Cham.
(marmelinho), higher than that found in this study. -Amylase is
194 T.R. Marques et al. / Revista Brasileira de Farmacognosia 26 (2016) 191–196
Table 1
Inhibition of digestive enzymes by acerola bagasse powder before and after the
exposure to simulated gastric ﬂuid.
Enzyme Inhibition (IEUb)a
Before exposure After exposure
-Amylase 238.96 ± 1.64 170.08 ± 1.06
-Glycosidase 78.51 ± 1.78 69.29 ± 0.28
Lipase ndc ndc
Trypsin 227.52 ± 3.59 84.73 ± 5.41
Data from three repetitions, with mean ± standard deviation.
a The ABF extract measured for each of the enzymes was diluted to provide an
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Table 2
Content of phenolic compounds in the methanol extract of acerola bagasse ﬂour,
used in each enzymatic assay.
Phenolic compound (g) Enzymatic assays
-Amylasea -Glycosidaseb Lipasec Trypsinc
Gallic acid 0.02 0.06 0.17 0.66
Catechin 0.07 0.19 0.57 2.26
Epigallocatechin-gallate 0.05 0.15 0.46 1.83
Epicatechin 0.54 1.53 4.60 18.4
Siringic acid 0.22 0.62 1.86 7.44
p-Cumaric acid 0.01 0.04 0.12 0.48
Quercetin 1.71 × 10−3 4.83 × 10−3 0.01 0.06
∑
Phenolic compounds 0.91 2.59 7.79 31.13
a Extract dilution 1:7.5.
bnhibition between 50% and 80%, in order to ensure result reliability.
b IEU = Inhibited Enzyme Unit in mol  min−1 g−1 dry matter – DM.
c nd = inhibition not detected.
elated with the digestion of carbohydrates and, consequently, with
he elevation in glycemic levels after a meal. High glycemic levels
ead to serious health problems in the population, such as type 2
iabetes. The intake food rich in -amylase poses as an interest-
ng strategy in the prevention and treatment of hyperglycemia, by
lowing postprandial glucose levels in blood after the ingestion of
arbohydrates (Vadivel et al., 2011).
The inhibition of -glucosidase by the ABF extract was  about
8.51 mol  min−1 g−1 DM.  The inhibitory potential of ABP found
n this paper surpasses the ones veriﬁed by Simão et al. (2012)
ho, studying aqueous extracts of medicinal plants like Aloe vera
L.) Burm. (Aloe), Simaba ferruginea St. Hil. (calunga), Baccharis
rimera (Less.) DC (carqueja), Garcinia cambogia Desr. (garcinia),
. paniculata Cham. (marmelinho), found inhibitions of 0.58 and
5.46 mol  min−1 g−1 DM,  as well as those from Pereira et al.
2011a), who analyzed commercial samples of Hoodia gordonni,
sed as an auxiliary in the treatment of obesity, and found inhi-
itions of 10.40 e 16.70 mol  min−1 g−1 DM.
The inhibition of -glucosidase extends gastric emptying, leads
o satiety and weight loss, effects which can be useful in the treat-
ent of obesity (Chen et al., 2008).
Therefore, the inhibition of -amylase and -glycosidase by
atural products can provide an alternative for the treatment of
besity in substitution to synthetic drugs now available on the mar-
et, besides controlling glucose levels in blood in type 2 diabetes
atients (McDougall et al., 2005a).
The ABF extract was not able to inhibit lipase, an enzyme
nvolved in lipid metabolism, neither before nor after the exposure
o simulated gastric ﬂuid. However, for trypsin, an inhibition of
27.52 mol  min−1 g−1 DM was observed. When trypsin inhibitors
re present in the diet, these may  lead to a reduction in growth rate
n animals, followed by a decrease in protein digestibility, leading to
eight loss and endogenous protein catabolism (McDougall et al.,
005a). Therefore, the trypsin inhibitor is considered an antinutri-
ional factor.
The passage of the ABF extract through the gastrointestinal cav-
ty may  lead to structural modiﬁcations on the inhibitors because
f the pH of the gastric acid. Considering the expressive inhibition
f -amylase, -glycosidase and trypsin in the presence of the ABF
xtract, this extract was submitted to a gastric ﬂuid assay (Table 1).
In the presence of simulated gastric ﬂuid, the ABF methanol
xtract still maintained 71% of its inhibitory activity over -amylase
nd 88% of inhibitory activity over -glycosidase. Therefore, the
xtract did not show a considerable inhibitory activity over these
wo enzymes after they were submitted to simulated gastric ﬂuid.
The ABF extract decreased the inhibition of trypsin by 63% in
he presence of simulated gastric ﬂuid. This reduction in trypsin
nhibition is considered positive since, when inhibition occurs, it
s considered antinutritional, impairing protein digestion, which
s the main source of essential amino acids. However, a residual
nhibitory activity of 37% was still observed. It is noted that theExtract dilution 1:2.
c Crude extract.
resistance of the inhibitor to pass through the simulated gastric
ﬂuid is a strong indicative that these results will repeat in in vivo
assays.
In this study, the inhibition of digestive enzymes can probably be
explained by the presence of phenolic compounds in the methanol
ABF extract, whose levels were different for each enzymatic assay
assessed (Table 2). -Amylase was the one that had the small-
est content of phenolic compounds, which led to an inhibition of
0.91 g. On the other hand, the content of phenolic compounds was
higher (31.13 g) for the trypsin assay, that is, 34 times superior
to that found for -amylase. Therefore, this suggests that smaller
contents of phenolic compounds may  not lead to trypsin inhibition,
which would be beneﬁcial, since it could reduce the absorption of
carbohydrates and allow protein digestion.
Gallic acid is considered a hydrolyzable tannin, when found in
the form of gallic acid esters, while catechin, epicatechin gallate and
epicatechin, when found in the form of ﬂavonoids, are considered
condensed tannins. These compounds have strong interactions
with metal ions and macromolecules such as polysaccharides,
besides the ability to form soluble complexes with several pro-
teins, as digestives enzymes (Won  et al., 2007; Gholamhoseinian
et al., 2010). This ability that tannins exhibit to interact with pro-
teins makes this class of substances powerful digestive enzyme
inhibitors.
McDougall et al. (2005b) report that red fruit extracts in phenolic
compounds inhibit two  main enzymes involved in starch diges-
tion, -amylase and -glycosidase, in vitro. In a similar way, recent
studies with red fruits reported inhibition of -amylase and -
glycosidase, and mentioned that tannins were the most effective
compounds in inhibiting these enzymes (Boath et al., 2012). Kam
et al. (2013), studying the effects of extracts from different parts
of pomegranate (pulp, peels, seeds and ﬂower) over the digestive
enzymes -amylase and -glycosidase, showed that the methanol
extract from the pomegranate ﬂower, where the phenolic com-
pounds gallic acid and ellagic acid are found, exhibits a potent
inhibitor effect on these enzymes.
Klaus et al. (2005) reported that rats fed epigallocatechin gallate,
puriﬁed from green tea, had an obesity decrease induced by the
diet, due to a reduction in energy absorption and an increase in
lipid oxidation. On the other hand, Bryans et al. (2007) reported
that black tea is efﬁcient in reducing postprandial blood glucose
levels and related this fact to the presence of phenolic compounds
such as epigallocatechin, epigallocatechin gallate, epicatechin and
epicatechin gallate.
Flavonoids like quercetin comprise a heterogeneous class
of phenolic compounds present in plants, which can also act
in the organism, inhibiting digestive enzymes. Wenzel (2013)
reported that quercetin is a promising enzyme inhibitor, limiting
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arbohydrate digestion and controlling postprandial glucose levels
n blood, thus conﬁrming the result obtained by Tadera et al. (2006),
ho reported the inhibitory activity of quercetin in the presence of
-amylase.
Lin and Lin-Shiau (2006), report that ﬂavonoids have the ability
o act on the sympathetic nervous system through the modulation
f noradrenaline, thus increasing thermogenesis and fat oxidation.
t also prevents the increase in the size and number of adipocytes,
herefore preventing the deposition of fat in the body and regulat-
ng body weight.
Phenolic extracts of lentils containing p-hydroxybenzoic acid,
yringic acid, trans-p-coumaric acid, epicatechin gallate, quercetin
nd kaempferol were shown to be good inhibitors of lipase and -
lycosidase, contributing to control glucose levels in blood, as well
s obesity (Zhang et al., 2015).
Most phenols previously mentioned were found in the ABF
xtract, which could have led to a complexation with digestive
nzymes and, probably, contributed to its inhibition. The inhibition
f digestive enzymes is a promising alternative for the treatment
f obesity and type 2 diabetes, especially by the fact they act in
he small intestine, without acting in the central nervous system,
here prescribed anorexigenic drugs usually act.
onclusion
The ABF methanol extract that contains the phenolic com-
ounds gallic acid, catechin, epicatechin gallate, epicatechin,
iringic acid, p-cumaric acid and quercetin, was  able to inhibit
n vitro digestive enzymes -amylase and -glucosidase. This
hows that the ABF extract may  represent a good source of
nhibitors, and can be used as an auxiliary in the treatment of obe-
ity, associated comorbidities and in the control of type 2 diabetes.
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